CorMedix, Inc. (NYSE MKT: CRMD) is a commercial-stage biopharmaceutical company seeking to in-license, develop and commercialize therapeutic products for the prevention and treatment of cardiac, renal and infectious diseases. The company’s first commercial product, Neutrolin®, is currently marketed in Europe … Continue reading →

Venaxis, Inc. (NASDAQ: APPY) is an in vitro diagnostic company focused on the development and commercialization of its leading product candidate, the APPY1™ Test. This novel blood-based diagnostic test is designed to aid in the evaluation of patients at low … Continue reading →

ClearSign Combustion Corp. (NASDAQ: CLIR) designs, develops and markets technologies that improve key performance characteristics of combustion systems – including emissions and operational performance, energy efficiency and overall cost-effectiveness. The company’s patent-pending Duplex™ and Electrodynamic Combustion Control™ (ECC) platform technologies … Continue reading →

Advanced Photonix, Inc. (NYSE MKT: API) is a leading supplier of optoelectronic sensors, devices and instruments used by original equipment manufacturers in vital markets around the globe. The company offers three innovative product lines designed to meet the needs of … Continue reading →

LightPath Technologies, Inc. (NASDAQ: LPTH) is a recognized leader in optics and photonics solutions, serving blue chip customers in the industrial, defense, telecommunications, testing and measurement, and medical industries for over a quarter of a century. The company designs, manufactures … Continue reading →

SofTech, Inc. (OTCQB: SOFT) enhances customer productivity and promotes profitability through the development, marketing and distribution of computer software solutions for the product lifecycle management (PLM) industry. In particular, the company’s proprietary ProductCenter® PLM solution enables users to automate product … Continue reading →

ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV) is a biopharmaceutical company focused on the development of targeted antiviral therapies. The company’s leading product candidate, FV-100, is currently in phase III clinical development for the treatment of shingles, as well as for the … Continue reading →

Neptune Technologies & Bioressources, Inc. (NASDAQ: NEPT) is a biotechnology company focused on the development and commercialization of products derived from marine biomasses for the nutraceutical and pharmaceutical industries. Leveraging a patented extraction process, the company produces nutrient-rich oils from … Continue reading →

Tonix Pharmaceuticals is a clinical-stage pharmaceutical company focused on the development of next-generation medications for disorders of the central nervous system. The company’s leading product candidate, Tonmya, is currently being evaluated in a phase III clinical study for the treatment … Continue reading →

Sonus Networks enables and secures real-time communications that allow the world’s leading service providers and enterprises to embrace the next generation of session initiated protocol (SIP) and 4G/VoLTE solutions – including voice over IP (VoIP), video, instant messaging and online … Continue reading →